HighMark Wealth Management LLC - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$115,519
+19.7%
4,5750.0%0.10%
+31.5%
Q2 2023$96,533
+23.8%
4,5750.0%0.07%
+19.7%
Q1 2023$78,004
-14.7%
4,5750.0%0.06%
-11.6%
Q4 2022$91,409
-7.7%
4,5750.0%0.07%
-18.8%
Q3 2022$99,000
+10.0%
4,5750.0%0.08%
+18.1%
Q2 2022$90,000
-16.7%
4,5750.0%0.07%0.0%
Q1 2022$108,000
-13.6%
4,5750.0%0.07%
-8.9%
Q4 2021$125,000
-10.7%
4,575
-10.1%
0.08%
-23.3%
Q3 2021$140,000
+2.2%
5,089
+1.4%
0.10%
+2.0%
Q2 2021$137,000
+522.7%
5,019
+675.7%
0.10%
+461.1%
Q1 2021$22,000
-26.7%
647
-28.6%
0.02%
-30.8%
Q4 2020$30,000
-76.9%
906
-77.5%
0.03%
-77.8%
Q3 2020$130,000
+622.2%
4,035
+503.1%
0.12%
+485.0%
Q2 2020$18,000
+200.0%
669
+67.2%
0.02%
+185.7%
Q1 2020$6,000
-33.3%
4000.0%0.01%
-30.0%
Q4 2019$9,0004000.01%
Other shareholders
INSMED INC shareholders Q1 2022
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 250,584$4,420,0009.48%
Palo Alto Investors LP 7,239,649$127,707,0008.51%
Foresite Capital Management IV, LLC 1,429,518$25,217,0008.15%
First Light Asset Management, LLC 1,294,743$22,839,0003.45%
Foresite Capital Management II, LLC 915,016$16,141,0003.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 356,600$6,287,0002.90%
ACUTA CAPITAL PARTNERS, LLC 220,000$3,881,0002.80%
EMERALD ADVISERS, LLC 984,987$17,375,0000.81%
EMERALD MUTUAL FUND ADVISERS TRUST 911,936$16,087,0000.71%
Rock Springs Capital Management LP 890,000$15,700,0000.63%
View complete list of INSMED INC shareholders